Circular Library

Publications

In the first year of the The Berkowitz Living Laboratory Collaboration, scientists have published landmark research on the effectiveness and safety of coronavirus vaccinations in real world settings. This research has been published in leading scientific journals, including The New England Journal of Medicine, The Lancet and Nature Medicine, and has been used by governments and health authorities to directly inform policy and improve pandemic response: 

Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernán MA, Lipsitch M, Reis B, Balicer RD. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. The New England Journal of Medicine. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765.

Barda N, Dagan N, Balicer RD. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply. The New England Journal of Medicine. 2021 May 20;384(20):1970. doi: 10.1056/NEJMc2104281.

Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, Hernán MA, Lipsitch M, Kohane I, Netzer D, Reis BY, Balicer RD. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. The New England Journal of Medicine. 2021 Sep 16;385(12):1078-1090. doi: 10.1056/NEJMoa2110475. 

Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, Hernán MA, Lipsitch M, Hernandez-Diaz S, Reis BY, Balicer RD. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nature Medicine. 2021 Oct;27(10):1693-1695. doi: 10.1038/s41591-021-01490-8.

Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, Grinberg T, Auster O, Dagan N, Balicer RD, Kornowski R. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. The New England Journal of Medicine. 2021 Oct 6:NEJMoa2110737. doi: 10.1056/NEJMoa2110737.

Reis BY, Barda N, Leshchinsky M, Kepten E, Hernán MA, Lipsitch M, Dagan N, Balicer RD. Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents. The New England Journal of Medicine. 2021 Oct 20:NEJMc2114290. doi: 10.1056/NEJMc2114290.
 
Dagan N, Barda N, Balicer RD. Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.  
The New England Journal of Medicine. 2021 Oct 27. doi: 10.1056/NEJMc2115045. 

Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M,  Kohane IS, Reis BY, Balicer RD. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. The Lancet. 2021 Oct 29. doi: 10.1016/S0140-6736(21)02249-2.